Navigation Links
Manual of Cardiovascular Diagnosis and Therapy, Fifth Edition

ProductsManual of Cardiovascular Diagnosis and Therapy, Fifth Edition
Company Skyscape, Inc.
Item Manual of Cardiovascular Diagnosis and Therapy, Fifth Edition
Features 
  • Available in a convenient electronic format
  • Easy-to-scan outline format
  • More than 100 tables provide quick access to essential information
  • With Skyscape's patented smARTlink™ technology, MnlCrd5™ can easily cross-index with other titles from Skyscape
Description On the wards, on rounds, or at the bedside, clinicians can instantly access authoritative, up-to-date, practical guidelines for the immediate and long-term medical and surgical management of all cardiovascular disorders.
Info Skyscape, Inc.
Customer Service: 508-460-6500

Related medicine products :

1. Cascade M Manual Coagulation Analyzer
2. Cascade M-4 Manual Coagulation Analyzer
3. Microplate Washers - EL401 Manual Washer
4. Microplate ELISA Washers - Manual Microplate Washer
5. ML1 Manual LENSOMETER
6. Manual "H" Instrument Table Base
7. Topcon PS-9 Manual Blocker
8. Manually Operated Tripod Stand
9. Shandon Cryotome Manual Cryostat
10. Shandon Manual Staining Station
11. Manual Radial Microtome - Economy Series
CRP Calibrator
Drug controls sera available in three levels for the control of accuracy and percision for up to 18 analytes
Human based material available in two levels for thecontrol of percision for up to 10 analytes
Human based assayed sera available in three levels for the control of accuracy and precision for up to 25 analytes
Medicine Products:
(Date:8/7/2008)...thcare leader continues support of activities fost...unities it serves, PASADENA, Calif., Aug. 7 /PRNe... a Pasadena-based nonprofit organization, today an...nting Sponsor of the 2008 Pasadena,Marathon. The i... 2008, is,the flagship event for Pasadena Forward....
(Date:8/7/2008)...WASHINGTON, Aug. 7 /PRNewswire-USNewswire/ -- The ...national Development (USAID), is providing,an init...ision of emergency,relief supplies to the flood-af..., heavy rains led to flooding in central and,south...gan and the capital,of Lome. The UN Development Pr...
(Date:8/7/2008)... a game of give and get, the brains of people with...t. , In fact, an interactive economic game playe...nce imaging (fMRI) devices revealed a brain malfun...common mental illness that affects a person,s perc...chers from Baylor College of Medicine in a report ...
(Date:8/7/2008)...ends signals, telling neurons to change connection... -- Scientists say they,re gaining insight into ho..., potentially helping them move toward better trea... Researchers report that a protein appears to tell...se new information is coming in. , While the st...
Breaking Medicine News(10 mins):Health News:Kaiser Permanente Becomes Presenting Sponsor for Pasadena Marathon 2Health News:A new light on the brains of people with borderline personality disorder 2Health News:A new light on the brains of people with borderline personality disorder 3Health News:Protein Key to Brain Rewiring 2
... could due to ineffective functioning of a weak im...ractive immune system could be responsible // for ...y ulcers in the small and large intestines. The fo...ducted by researchers from University College Lond...
...re staring human trials for testing the efficacy o.../AIDS as well as hepatitis B. The chemical, 1,5-di... from a Chinese herb called Inula britannic, has w...nxing, a leading scientist with the Academy of Mil...
...n if not needed they should be asked to pay. This ...ts at Royal College of Midwives (RCM). They said t...omen asking for the injection. About 20% of pregna... costs about ?500 in a private maternity hospital....
...eserve the rare herbal plants that are on the verg...oga guru Ramdev in setting up the herbarium.// Th...l set up the herbarium at Bariatu in Ranchi with a... Ramdev's Patanjali Yoga Peeth will collaborate wi...
Other Medicine News:Health News:Viagra Offers Hope In Treatment Of Crohn’s Diseas 2
(Date:8/6/2008).... 6 /- In the most recent issue of,Op...blished by German,scientist and researcher, Dr. Bu...ren with vision problems have a hard time learning...iate vision therapy is given,math skills improve.... German television news,programs which reported on...
(Date:8/5/2008)...p: Building Comprehensive HIV/AIDS Care Programs i... Than 230 Global Health,Experts, MEXICO CITY, Aug...r,Pediatric AIDS Foundation, with support from the...undation, the U.S. Government, Harvard,University ...o improving,and expanding HIV/AIDS prevention, car...
(Date:8/5/2008)...and Non-Whites New to Antiretroviral Therapy Respo...s, MEXICO CITY, Aug. 5 /- ...r twice-daily dosing of Abbott,s (NYSE:,ABT) prote...let provided,similar results for controlling the v...the immune system (increasing CD4 cells) in women ...
(Date:8/5/2008)...ron-Beta-CTP Development Program Has Been Approved...rom the Israeli Office of the ...5 /- Modigene Inc. (OTC,Bul...-based R&D subsidiary,has received approval for a ... Scientist ("OCS") in support of the company,s dev...
Breaking Medicine Technology:Vision Problems Affect How Children Learn Math Skills 2Landmark HIV/AIDS Publication Launches at International AIDS Society Conference in Mexico City 2Landmark HIV/AIDS Publication Launches at International AIDS Society Conference in Mexico City 3Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 2Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 3Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 4Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 5Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 6Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 7Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 8Modigene Awarded Israeli Government Grant to Support Development of Its Longer-Acting Interferon Beta 2Modigene Awarded Israeli Government Grant to Support Development of Its Longer-Acting Interferon Beta 3Modigene Awarded Israeli Government Grant to Support Development of Its Longer-Acting Interferon Beta 4Young Pop Stars Emphysema Startles Experts 22570 1Young Pop Stars Emphysema Startles Experts 22570 2Young Pop Stars Emphysema Startles Experts 22570 3Dr Torrey Takes The Insanity Offense 22568 1Dr Torrey Takes The Insanity Offense 22568 2RF Technologies 28R 29 Introduces Enhanced Clinical Support Service Step by Step a Comprehensive Program Designed to Ensure Infant Security 22566 1RF Technologies 28R 29 Introduces Enhanced Clinical Support Service Step by Step a Comprehensive Program Designed to Ensure Infant Security 22566 2BioHorizons Global Symposium 2008 Combines Record Attendance with Groundbreaking Technology 6161 1BioHorizons Global Symposium 2008 Combines Record Attendance with Groundbreaking Technology 6161 2
...S WIRE)--Apr 19, 2007 - Othera Pharmaceuticals,In...r of,Pharmacology and Executive Vice President and... at Albany College of Pharmacy,will present new p...tic effect of Othera,s lead compound, OT-551, and,...vious ocular,studies on OT-551 eye drops, as well ...
...SS WIRE)--Apr 19, 2007 - Abraxis BioScience,Inc. ...ical,company, presented first-time data from a pre...mor effect of nab-rapamycin,(ABI-009), an albumin-...Association for Cancer Research (AACR) Annual Meet... from the pre-clinical,study demonstrated that nab...
Other Medicine Technology:Othera Pharmaceuticals Announces Upcoming Presentation Based Upon,Expanded Understanding of Lead Compound Mechanism of Action 2Othera Pharmaceuticals Announces Upcoming Presentation Based Upon,Expanded Understanding of Lead Compound Mechanism of Action 3Othera Pharmaceuticals Announces Upcoming Presentation Based Upon,Expanded Understanding of Lead Compound Mechanism of Action 4Abraxis BioScience Presents Results from Pre-Clinical Study That,Demonstrates nab-Rapamycin's Robust Antitumor Properties and,Ability to Target Intracellular Sites Such as the mTOR Pathway 2Abraxis BioScience Presents Results from Pre-Clinical Study That,Demonstrates nab-Rapamycin's Robust Antitumor Properties and,Ability to Target Intracellular Sites Such as the mTOR Pathway 3Abraxis BioScience Presents Results from Pre-Clinical Study That,Demonstrates nab-Rapamycin's Robust Antitumor Properties and,Ability to Target Intracellular Sites Such as the mTOR Pathway 4